Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Related Articles by Review for PubMed (Select 18606850)

1.

TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha.

Vince JE, Chau D, Callus B, Wong WW, Hawkins CJ, Schneider P, McKinlay M, Benetatos CA, Condon SM, Chunduru SK, Yeoh G, Brink R, Vaux DL, Silke J.

J Cell Biol. 2008 Jul 14;182(1):171-84. doi: 10.1083/jcb.200801010. Epub 2008 Jul 7.

2.

Role of the TWEAK-Fn14-cIAP1-NF-κB Signaling Axis in the Regulation of Myogenesis and Muscle Homeostasis.

Enwere EK, Lacasse EC, Adam NJ, Korneluk RG.

Front Immunol. 2014 Feb 5;5:34. doi: 10.3389/fimmu.2014.00034. eCollection 2014. Review.

3.

Role of tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in rheumatic diseases.

Zhu LX, Zhang HH, Mei YF, Zhao YP, Zhang ZY.

Chin Med J (Engl). 2012 Nov;125(21):3898-904. Review.

PMID:
23106895
4.
5.

TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases.

Blanco-Colio LM.

Front Immunol. 2014 Jan 20;5:3. doi: 10.3389/fimmu.2014.00003. eCollection 2014. Review.

6.

TNF superfamily: a growing saga of kidney injury modulators.

Sanchez-Niño MD, Benito-Martin A, Gonçalves S, Sanz AB, Ucero AC, Izquierdo MC, Ramos AM, Berzal S, Selgas R, Ruiz-Ortega M, Egido J, Ortiz A.

Mediators Inflamm. 2010;2010. pii: 182958. doi: 10.1155/2010/182958. Epub 2010 Oct 4. Review.

7.

Smac mimetics and TNFalpha: a dangerous liaison?

Wu H, Tschopp J, Lin SC.

Cell. 2007 Nov 16;131(4):655-8. Review.

8.

TWEAK/Fn14 and Non-Canonical NF-kappaB Signaling in Kidney Disease.

Poveda J, Tabara LC, Fernandez-Fernandez B, Martin-Cleary C, Sanz AB, Selgas R, Ortiz A, Sanchez-Niño MD.

Front Immunol. 2013 Dec 10;4:447. doi: 10.3389/fimmu.2013.00447. Review.

9.

The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting.

Winkles JA.

Nat Rev Drug Discov. 2008 May;7(5):411-25. doi: 10.1038/nrd2488. Review.

10.

TWEAK/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction.

Sato S, Ogura Y, Kumar A.

Front Immunol. 2014 Jan 27;5:18. doi: 10.3389/fimmu.2014.00018. eCollection 2014. Review.

11.

The role of TWEAK/Fn14 in cardiac remodeling.

Ren MY, Sui SJ.

Mol Biol Rep. 2012 Nov;39(11):9971-7. Epub 2012 Jun 30. Review.

PMID:
22752727
12.

Acute kidney injury transcriptomics unveils a relationship between inflammation and ageing.

Izquierdo MC, Sanz AB, Sánchez-Niño MD, Pérez-Gómez MV, Ruiz-Ortega M, Poveda J, Ruiz-Andrés O, Ramos AM, Moreno JA, Egido J, Ortiz A.

Nefrologia. 2012;32(6):715-23. doi: 10.3265/Nefrologia.pre2012.Aug.11667. Epub 2012 Oct 23. Review.

13.

TWEAK-Fn14 Cytokine-Receptor Axis: A New Player of Myocardial Remodeling and Cardiac Failure.

Novoyatleva T, Sajjad A, Engel FB.

Front Immunol. 2014 Feb 11;5:50. doi: 10.3389/fimmu.2014.00050. eCollection 2014. Review.

14.

TWEAK and Fn14 in the Neurovascular Unit.

Yepes M.

Front Immunol. 2013 Nov 11;4:367. doi: 10.3389/fimmu.2013.00367. eCollection 2013. Review.

15.

Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation.

Silke J, Meier P.

Cold Spring Harb Perspect Biol. 2013 Feb 1;5(2). pii: a008730. doi: 10.1101/cshperspect.a008730. Review.

16.

Regulatory Tweak/Fn14 signaling pathway as a potent target for controlling bone loss.

Du YY, Zhao YX, Liu YP, Liu W, Wang MM, Yuan CM.

Biomed Pharmacother. 2015 Mar;70:170-3. doi: 10.1016/j.biopha.2015.01.005. Epub 2015 Jan 23. Review.

PMID:
25776497
17.

TWEAK: A New Player in Obesity and Diabetes.

Vendrell J, Chacón MR.

Front Immunol. 2013 Dec 30;4:488. doi: 10.3389/fimmu.2013.00488. Review.

18.

IAPs on the move: role of inhibitors of apoptosis proteins in cell migration.

Oberoi-Khanuja TK, Murali A, Rajalingam K.

Cell Death Dis. 2013 Sep 5;4:e784. doi: 10.1038/cddis.2013.311. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk